How an HIV Trial Triggered a 667% Jump in Australian Penny Stock...
The Sydney-based drug company with just five full-time employees last week announced the “successful” outcome of a phase-two trial of BIT225 HIV-1 drug and retail investors have been lapping it up. The company said its therapy suppressed the HIV virus more than current antiretrovirals.https://finance.yahoo.com/news/hiv-trial-triggered-667-jump-052713187.html
Market Data 
Markets 
AI
